Bioexplorer
Explorer
There's something of a consensus around here that tirzepitide is the best of them for inflammation, with plenty of anecdotal reports that this particular dual agonist eases various ailments better than semaglutide or retatrutide. And a number of members say they moved from Reta to Tirz specifically to get that effect.
But hs-CRP is broadly accepted as the best marker of systemic inflammation, so a non-subjective way of measuring inflammation reduction is already available to us. 10mg Tirz produced a 34% reduction. EL reports a substantial reduction in the Reta trials, though I haven't come across any figures. Still, judging by the liver and kidney effects, a lot of people expect a bigger drop in hs-CRP than Tirz manages.
Have I missed some data with actual CRP numbers for Reta? And any thoughts on why Tirz might give a better subjective effect on inflammation when Reta probably delivers similar hs-CRP benefits?
But hs-CRP is broadly accepted as the best marker of systemic inflammation, so a non-subjective way of measuring inflammation reduction is already available to us. 10mg Tirz produced a 34% reduction. EL reports a substantial reduction in the Reta trials, though I haven't come across any figures. Still, judging by the liver and kidney effects, a lot of people expect a bigger drop in hs-CRP than Tirz manages.
Have I missed some data with actual CRP numbers for Reta? And any thoughts on why Tirz might give a better subjective effect on inflammation when Reta probably delivers similar hs-CRP benefits?